- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.85 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLY: GLYCINE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)
ACP.3: 11 residues within 4Å:- Chain A: Y.351, I.359, G.380, S.381, G.382, K.383, S.384, T.385, Y.394, Q.425
- Ligands: MG.2
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:G.380, A:S.381, A:G.382, A:K.383, A:K.383, A:S.384, A:T.385, A:Y.394, A:Q.425, A:Q.425
- pi-Stacking: A:Y.351, A:Y.351
ACP.13: 11 residues within 4Å:- Chain B: Y.351, I.359, G.380, S.381, G.382, K.383, S.384, T.385, Y.394, Q.425
- Ligands: MG.12
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:G.380, B:S.381, B:G.382, B:K.383, B:K.383, B:S.384, B:T.385, B:T.385, B:Y.394, B:Y.394, B:Q.425
- pi-Stacking: B:Y.351, B:Y.351
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.4: 15 residues within 4Å:- Chain A: D.47, Y.50, T.51, L.264, G.268, M.271, T.277, V.278
- Chain B: I.49, P.53, Y.57, L.61, L.64, L.68
- Ligands: CDL.20
12 PLIP interactions:6 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:L.264, A:M.271, B:Y.57, B:L.61, B:L.61, B:L.64, B:L.68
- Hydrogen bonds: A:D.47, A:D.47, A:Y.50, A:V.278, B:P.53
LMT.6: 8 residues within 4Å:- Chain A: I.154, M.157, A.165, L.169, V.172, S.176, I.295
- Ligands: LMT.7
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.154, A:V.172, A:I.295
LMT.7: 6 residues within 4Å:- Chain A: V.172, A.288, V.291, I.295, S.299
- Ligands: LMT.6
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.172, A:V.291, A:I.295
LMT.8: 12 residues within 4Å:- Chain A: N.163, F.167, S.255, L.258, I.259, S.262, Y.265, K.266, L.269, L.270, H.275
- Ligands: CDL.5
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.167, A:L.258, A:I.259, A:Y.265
- Hydrogen bonds: A:N.163, A:N.163
- Salt bridges: A:K.266, A:K.266
LMT.14: 15 residues within 4Å:- Chain A: I.49, P.53, Y.57, L.61, L.64, L.68
- Chain B: D.47, Y.50, T.51, L.264, G.268, M.271, T.277, V.278
- Ligands: CDL.10
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:Y.57, A:L.61, A:L.61, A:L.64, A:L.68, B:L.264, B:M.271
- Hydrogen bonds: A:P.53, B:D.47, B:V.278
LMT.16: 8 residues within 4Å:- Chain B: I.154, M.157, A.165, L.169, V.172, S.176, I.295
- Ligands: LMT.17
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.154, B:V.172, B:I.295
LMT.17: 6 residues within 4Å:- Chain B: V.172, A.288, V.291, I.295, S.299
- Ligands: LMT.16
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:V.172, B:V.291, B:I.295
LMT.18: 12 residues within 4Å:- Chain B: N.163, F.167, S.255, L.258, I.259, S.262, Y.265, K.266, L.269, L.270, H.275
- Ligands: CDL.15
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:F.167, B:L.258, B:I.259, B:Y.265
- Hydrogen bonds: B:N.163, B:N.163
- Salt bridges: B:K.266, B:K.266
- 4 x CDL: CARDIOLIPIN(Non-covalent)
CDL.5: 12 residues within 4Å:- Chain A: F.158, P.162, N.163, T.166, F.167, L.169, V.171, P.174, V.175, I.178, K.266
- Ligands: LMT.8
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:F.158, A:F.158, A:P.162, A:L.169, A:V.171, A:P.174, A:V.175, A:I.178
- Hydrogen bonds: A:N.163, A:N.163, A:T.166, A:S.170
- Salt bridges: A:K.266
CDL.10: 8 residues within 4Å:- Chain A: F.41, L.42, I.45, L.64
- Chain B: N.257, V.260, L.264
- Ligands: LMT.14
8 PLIP interactions:5 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.41, A:F.41, A:L.42, A:I.45, A:L.64, B:V.260, B:V.260, B:L.264
CDL.15: 12 residues within 4Å:- Chain B: F.158, P.162, N.163, T.166, F.167, L.169, V.171, P.174, V.175, I.178, K.266
- Ligands: LMT.18
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:F.158, B:F.158, B:P.162, B:L.169, B:V.171, B:P.174, B:V.175, B:I.178
- Hydrogen bonds: B:N.163, B:N.163, B:S.170
- Salt bridges: B:K.266
CDL.20: 8 residues within 4Å:- Chain A: N.257, V.260, L.264
- Chain B: F.41, L.42, I.45, L.64
- Ligands: LMT.4
8 PLIP interactions:5 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:F.41, B:F.41, B:L.42, B:I.45, B:L.64, A:V.260, A:V.260, A:L.264
- 2 x 14Y: METHYL(E)-OCTADEC-9-ENOATE(Non-covalent)
14Y.9: 7 residues within 4Å:- Chain A: F.27, M.30, S.31, I.34, V.71
- Chain B: G.253, N.257
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.27, A:F.27, A:M.30, A:I.34, A:V.71
- Hydrogen bonds: B:N.257
14Y.19: 7 residues within 4Å:- Chain A: G.253, N.257
- Chain B: F.27, M.30, S.31, I.34, V.71
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:F.27, B:F.27, B:M.30, B:I.34, B:V.71
- Hydrogen bonds: A:N.257
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pike, A.C.W. et al., Structure of the Human Mitochondrial Abc Transporter, Abcb10. To be Published
- Release Date
- 2012-01-25
- Peptides
- ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10, MITOCHONDRIAL: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.85 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLY: GLYCINE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 4 x CDL: CARDIOLIPIN(Non-covalent)
- 2 x 14Y: METHYL(E)-OCTADEC-9-ENOATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pike, A.C.W. et al., Structure of the Human Mitochondrial Abc Transporter, Abcb10. To be Published
- Release Date
- 2012-01-25
- Peptides
- ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10, MITOCHONDRIAL: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.